114 related articles for article (PubMed ID: 26942090)
1. The extent to which melanoma alters tissue-resident dendritic cell function correlates with tumorigenicity.
Hargadon KM
Oncoimmunology; 2016; 5(1):e1069462. PubMed ID: 26942090
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells.
Hargadon KM; Bishop JD; Brandt JP; Hand ZC; Ararso YT; Forrest OA
Immunol Cell Biol; 2016 Jan; 94(1):24-38. PubMed ID: 26010746
[TBL] [Abstract][Full Text] [Related]
3. Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells.
Tucci M; Passarelli A; Mannavola F; Felici C; Stucci LS; Cives M; Silvestris F
Front Oncol; 2019; 9():1148. PubMed ID: 31750245
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the maturation and activation of the dendritic cell line DC2.4 by melanoma-derived factors.
Hargadon KM; Forrest OA; Reddy PR
Cell Immunol; 2012; 272(2):275-82. PubMed ID: 22051048
[TBL] [Abstract][Full Text] [Related]
5. The immune escape in melanoma: role of the impaired dendritic cell function.
Tucci M; Stucci S; Passarelli A; Giudice G; Dammacco F; Silvestris F
Expert Rev Clin Immunol; 2014 Oct; 10(10):1395-404. PubMed ID: 25225774
[TBL] [Abstract][Full Text] [Related]
6. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity.
Abdel-Wahab Z; DeMatos P; Hester D; Dong XD; Seigler HF
Cell Immunol; 1998 May; 186(1):63-74. PubMed ID: 9637766
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions.
Falcón-Beas C; Tittarelli A; Mora-Bau G; Tempio F; Pérez C; Hevia D; Behrens C; Flores I; Falcón-Beas F; Garrido P; Ascui G; Pereda C; González FE; Salazar-Onfray F; López MN
Immunobiology; 2019 Sep; 224(5):697-705. PubMed ID: 31221438
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.
Bol KF; Aarntzen EH; Pots JM; Olde Nordkamp MA; van de Rakt MW; Scharenborg NM; de Boer AJ; van Oorschot TG; Croockewit SA; Blokx WA; Oyen WJ; Boerman OC; Mus RD; van Rossum MM; van der Graaf CA; Punt CJ; Adema GJ; Figdor CG; de Vries IJ; Schreibelt G
Cancer Immunol Immunother; 2016 Mar; 65(3):327-39. PubMed ID: 26861670
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma.
Enk AH; Jonuleit H; Saloga J; Knop J
Int J Cancer; 1997 Nov; 73(3):309-16. PubMed ID: 9359474
[TBL] [Abstract][Full Text] [Related]
10. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations.
McMenamin PG
J Comp Neurol; 1999 Mar; 405(4):553-62. PubMed ID: 10098945
[TBL] [Abstract][Full Text] [Related]
11. Tumor-host immune interactions and dendritic cell dysfunction.
Yang L; Carbone DP
Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
[TBL] [Abstract][Full Text] [Related]
12. Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression.
Díaz-Valdés N; Basagoiti M; Dotor J; Aranda F; Monreal I; Riezu-Boj JI; Borrás-Cuesta F; Sarobe P; Feijoó E
Cancer Res; 2011 Feb; 71(3):812-21. PubMed ID: 21159663
[TBL] [Abstract][Full Text] [Related]
13. Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence.
van den Hout MFCM; Koster BD; Sluijter BJR; Molenkamp BG; van de Ven R; van den Eertwegh AJM; Scheper RJ; van Leeuwen PAM; van den Tol MP; de Gruijl TD
Cancer Immunol Res; 2017 Nov; 5(11):969-977. PubMed ID: 28935649
[TBL] [Abstract][Full Text] [Related]
14. Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation.
Jackson AM; Mulcahy LA; Zhu XW; O'Donnell D; Patel PM
Int J Cancer; 2008 Aug; 123(3):623-32. PubMed ID: 18478568
[TBL] [Abstract][Full Text] [Related]
15. Interferon-α2b enhances survival and modulates transcriptional profiles and the immune response in melanoma patients treated with dendritic cell vaccines.
Sheng L; Chen X; Wang Q; Lyu S; Li P
Biomed Pharmacother; 2020 May; 125():109966. PubMed ID: 32014686
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides inhibit the development from monocytes to dendritic cells.
Wölfl M; Batten WY; Posovszky C; Bernhard H; Berthold F
Clin Exp Immunol; 2002 Dec; 130(3):441-8. PubMed ID: 12452834
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369
[TBL] [Abstract][Full Text] [Related]
18. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions.
Gerlini G; Tun-Kyi A; Dudli C; Burg G; Pimpinelli N; Nestle FO
Am J Pathol; 2004 Dec; 165(6):1853-63. PubMed ID: 15579430
[TBL] [Abstract][Full Text] [Related]
19. Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro.
Marton A; Vizler C; Kusz E; Temesfoi V; Szathmary Z; Nagy K; Szegletes Z; Varo G; Siklos L; Katona RL; Tubak V; Howard OM; Duda E; Minarovits J; Nagy K; Buzas K
Immunol Lett; 2012; 148(1):34-8. PubMed ID: 22898052
[TBL] [Abstract][Full Text] [Related]
20. Human uveal melanoma cells inhibit the immunostimulatory function of dendritic cells.
Ma J; Usui Y; Takeuchi M; Okunuki Y; Kezuka T; Zhang L; Mizota A; Goto H
Exp Eye Res; 2010 Oct; 91(4):491-9. PubMed ID: 20624388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
